Саргин 42 мг/мл раствор для инфузий

Negara: Kirgistan

Bahasa: Rusia

Sumber: Правительства Кыргызской Республики (Департамент лекарственного обеспечения и медицинской техники)

Bahan aktif:

Аргинин гидрохлорид

Tersedia dari:

ПАО Фармак (ПАО Фармак)

Kode ATC:

B05XB01

INN (Nama Internasional):

Arginine hydrochloride

Dosis:

42 мг/мл

Bentuk farmasi:

раствор для инфузий

Unit dalam paket:

100 мл

Jenis Resep:

по рецепту

Diproduksi oleh:

ПАО Фармак (Украина)

Ringkasan produk:

ПЖВЛС: нет

Tanggal Otorisasi:

2019-12-13

Karakteristik produk

vTItEPXAAIO
3auecrureJrr,
AI{PeKroP
a
fleuaprameHTa
JIeKaPcTBeHHoro
o6ecueqen
ilfl
kt
tfi€
Atlrluncxofi
TexHrrKI'I
MunuclepcrBa
3ApaB()oxpallenuq
"-4,9e
,
tl'
2019r.
TTI]C]]I'YH
I\-ILflTIO
MEAIIUI4HCKOMY
TIPI'{MEHEHI4IO
JTEKAPC]TB]DHIIOfO
IIPETIAPATA
CAPI[IH
Totrlronoe
Ha3BaHIre:
CaPrun
NleX,rt),:napOAHOe
HeIIaTeHTOBaHHOe
HanMeHOBaHue:
Apruuuna
rl4ApOxnOpIIA
Cocmae:
deilcmeynu4r
r
rlr4r
r*eo
:
L-atginini
hydrochloridum;
1
nar
pacrnopa
c[aepxur
L-apruru'Iua
rllApoxnopl4Aa
42
tr,r;
lcnot4o?amenuul
e
seule
cmeo
:
BoAa,4nfi
Iaureruufi
'
JlercapcrneHHafl
QoPua.
P'acrnop
4nr
un@ysuft.
0uucanue
llpOalliaunar,
fiegUserHAs.17^II14
CJIerKa
xenTOBaTO-KOpI4r{HeBiU
X}IAKOCTb'
Oaprvranoreprf,
+eBruqecKaq
rpyrna.
Kponesanaeuu:re[rr'r
14
uep(pysraounue
BrryrpIIBeHHoI'o
BBeAenus.
ANfl{HoKI4cJIorEI.
Kor
ATX
B05;X
801.
I(slprurcroi^)>qffi"y/
flxannopo3oBa
M.
Y,\iryt;%/
'
pacrBopbl.
ApuomulreJlbHble
pacrBopu
Aprunuua
ru4foxnopIa4.
Ant
@
apnaxono
z
ufe
cxue
c
e
o
ficme
a.
@ap,vaxoduntr"n\urca.
Apruuus
(cr-hi,auno-6-ryanuguHoBanep[aHoBiul
KllcnoTa)
aMI'IHoKI'tcJIora,
Koroptul
nprruA,ra*r,
k
KIIaccy
ycJroBHo
He3aMeHI4MbIx
aMI,IHoKI'IcJIor
u
flBJIflercfl
aKTI'IBHEIM
14
,L""*"0"r*,r[,
KJrerorrHbrM
peryJrflTopoM
MHorotII{cJIeH[rbIx
xIr3HeHHo
BaxHbIx
Syuxultff
^op.unra*u,
,n$orrnre,
BaxHbre
B
Kpr.rrr{qecKoM
cocroqHulr
OpraH}BMa
nporeKTopHbl9
o$i[ermr.
Capruu
upOxs.r[ret
aIrTI{r}IIIoKCLIqecKyro,
l'relra6pauocraluttuzupyloqyrc,
q}ITorIpoTeKTopHyIo'
;;;.d;,lyo,
aHrr4paAlrKirrrbHyro,
AffirIHroKcLIKaIIroHHyIo
aKrI'IBHocrb,
npoflBrltrer
ce6'
KaK aKTr4BHrrfi
fleryuTop
[poMexyToqHolo
o6ueua
rt
flpoueccoB
SHeproo6ecneqenuf,,
I{rpaer
o[peAeJreHryof
po6
s
nogepxaH]rr.r
ropMoHaJlbHoro
6alauca
B
opraHl'I3rrae.
I'IgsecrHo,
tITo
upirr6
ynerdqusaer
coAepxaHr{e
B
KpoBr,r
rrr,cytuHa,
rJr}oKarona,
coMarorpolHoro
ropMoHa
,
,r6r*rtrHil,
flptIHI,IMaeT
yqaCTUe B
CI,IHT030
npOnI{Ha,
IIOJII'IaIUI'IHa'
afMaTUHa,
BKJIIOqaeTC'
B
npouarru,
qpr,{6pLrHoreuoJlu3a,
cflepMaroreHe3a,
oKa3blBaer
Irleu6pano4enon'p[3yloEee
Aeficreue.
AnrUnnn
XnfUbrCr
OAHIIM
lI3
OCHOBHTx
cy6c